Were Fossil Group Inc (FOSL)’s 63% Q1 Gains Just the Tip of the Iceberg?
Fossil Group Inc (NASDAQ:FOSL) was one of the top performing stocks on the Nasdaq in the first quarter, jumping by 63.5%. Much of that love from the market......(read more)
Stock Analysis
How High Can Bank of America Stock Go?
Financial stocks are on the cusp of a momentous year ahead. Barring the February 2018 market correction, banking and financial stocks are on the way up......(read more)
Phyto Partners: A Venture Capital Fund Worth Following In The Marijuana Industry
Insider Monkey is in the business of identifying and following smart insiders, hedge fund managers and prominent investors. Our flagship investment strategy......(read more)
Netflix, Inc. (NFLX): Key Metrics Are Deteriorating Says Billionaire Einhorn
Netflix, Inc. (NASDAQ:NFLX) remains a major target of billionaire hedge fund manager David Einhorn of Greenlight Capital, who’s been launching verbal......(read more)
Discover Financial Services (DFS): The Rodney Dangerfield of the Credit Industry
Discover Financial Services (NYSE:DFS) doesn’t get no respect. That’s the message from Burr Capital LLC’s Rahul Ray, who discussed the......(read more)
Tesla Inc (TSLA) Presentation: Full Transcript of Chamath Palihapitiya’s Scintillating Sohn Pitch
We published an article this morning providing a detailed breakdown of the Sohn Investment Conference presentation made by Social Capital CEO Chamath......(read more)
Exclusive Breakdown of Tesla Inc (TSLA)’s 2022 Convertible Notes And Why You Should Buy Them
Social Capital CEO Chamath Palihapitiya was one of the show-stoppers at the recent Sohn Investment Conference in New York, pitching a Tesla Inc (NASDAQ......(read more)
International Game Technology Ordinary Shares (IGT): Why Double Down Interactive Sale Was a Coup
International Game Technology Ordinary Shares (NYSE:IGT) scored a very favorable deal with the sale of its Double Down Interactive unit according to commentary......(read more)
TrueCar Inc (TRUE): Will “Poor Earnings Quality” Crash This Stock?
William Martin of Raging Capital Management believes TrueCar Inc (NASDAQ:TRUE) investors should pay attention to objects in their investment’s rear......(read more)
Lions Gate Entertainment Corp. (USA) (LGF): Why Passive Investing Could Be To Blame For Lagging Stock
Lions Gate Entertainment Corp. (USA) (NYSE:LGF) investors can probably point at least some of the blame for Lions Gate’s lackadaisical stock performance......(read more)
Honeywell International Inc. (HON): Why Dan Loeb’s $20 Billion Spinoff Proposal May Be Far-Fetched
Billionaire Dan Loeb, the head of $15 billion hedge fund Third Point, has his eyes set on a $20 billion prize. The money manager’s first-quarter......(read more)
International Business Machines Corp. (IBM): Warren Buffett’s Worst Investment?
Warren Buffett of Berkshire Hathaway has been an investing machine for five decades, delivering stunning returns during that time. A mere $1,000 invested......(read more)
Tesla Inc (TSLA): Billionaire David Einhorn’s Unflattering Image of Tesla Investors
David Einhorn, the billionaire manager of Greenlight Capital doesn’t exactly have a positive image of Tesla Inc (NASDAQ:TSLA) investors, viewing......(read more)
Tesla Inc (TSLA): Is It Doomed to the Same Fate As Radio Stocks?
Vilas Capital is probably no stranger to Tesla Inc (NASDAQ:TSLA) investors, as the fund has been an outspoken critic of Tesla in the past, calling it &#......(read more)
Cliffs Natural Resources Inc. (CLF): Why You Should Pay Attention to Burgeoning Insider Buying
Cliffs Natural Resources Inc. (NYSE:CLF) insiders have a history of buying up shares in clusters, the last cluster of which we saw in late-October/early......(read more)
Thermo Fisher Scientific Inc. (TMO): Why Billionaire Larry Robbins Loves This Stock
It’s been a tough run for Glenview Capital, the hedge fund run by billionaire Larry Robbins, which has endured two losing years in a row (an 18.......(read more)
Why The Corbus Pharmaceuticals Holdings Inc (CRBP) Cystic Fibrosis Results Are Very Positive
Last week, Corbus Pharmaceuticals Holdings Inc (NASDAQ:CRBP) announced data from a Phase II study of its lead development asset Anabasum. The data appeared......(read more)
The Threat And Risk Of Rising Interest Rates: Separating Fact From Fiction
Introduction The threat of rising interest rates is all the rage in financial circles today. However, the seminal question is: How real is the threat,......(read more)
Cannabis Space Continues To Shine As Latest IPO Therapix BioSciences (TRPX) Oversubscribed
The cannabis space has been one of the most closely watched, and the most active, sectors across the last twelve months. The Viridian Cannabis Stock Index......(read more)
FDA Sends Complete Response Letter To AstraZeneca PLC (ADR) (AZN) Following Rejection Of Hyperkalemia Drug
AstraZeneca PLC (ADR) (NYSE:AZN) has acknowledged the receipt of the Complete Response Letter (CRL) from the U.S. Food and Drug Administration for ZS......(read more)
Nektar Therapeutics (NKTR): Here’s What Just Happened
Nektar Therapeutics (NASDAQ:NKTR) is one of the week’s biggest winners in biotech so far, with the company soaring during the Monday session on the......(read more)
AstraZeneca PLC (ADR) (AZN) In Respiratory Drug Deal With Circassia Pharmaceuticals
In an effort to enhance collaboration with Circassia Pharmaceuticals, AstraZeneca PLC (ADR) (NYSE:AZN) has acquired an equity stake valued at $50 million......(read more)
Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Launches Minastrin Generic In The United States
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has unveiled the authorized generic version of Minastrin, an oral contraceptive that is combined......(read more)
Esperion Therapeutics Inc (ESPR): Get It While It’s Cheap
At the end of last week, Amgen, Inc. (NASDAQ:AMGN) announced some data from its large-scale trial of its cardiovascular risk asset Repatha. The drug first......(read more)
Two REITs Delivering High Growing Income For Retirees
As you know, I review the list of dividend increases every single week as part of my monitoring process. I usually focus my attention on the ones that......(read more)
Positive Results Reported For Ocular Therapeutix Inc (OCUL) Dextenza Following Phase III Study
Positive results for the Phase III study meant to test the experiences of patients using the eye insert known as Dextenza to relieve pain in a post-surgical......(read more)
Seres Therapeutics Inc (MCRB) Announces New “Poop Pill” Phase 2 Study
Plans to start a new Phase II study of SER-109, branded ECOSPOR III, have been announced by Seres Therapeutics Inc (NASDAQ:MCRB). The drug is meant to......(read more)
Target Corporation (TGT): An Attractively Valued Dividend Champion On Sale
Target Corporation (NYSE:TGT) operates general merchandise stores in the United States and Canada. Target is a dividend champion, which has paid dividends......(read more)
Biotech Movers On Friday: Neurotrope Inc (NTRP) And PTC Therapeutics, Inc. (PTCT)
Here’s a look at some of the week’s biggest movers in biotech, what’s moving them, and where we expect things to go early next week and beyond.......(read more)
Transcatheter Device By Medtronic PLC (MDT) Gets FDA Nod
The Melody Transcatheter Pulmonary Valve that has been developed by Medtronic PLC. Ordinary Shares (NYSE:MDT) has been approved by the U.S. Food and Drug......(read more)
Merck & Co., Inc. (MRK) Sued By Numerous Plaintiffs Over Harm Caused By Its Zostavax Drug
Reports indicate that there are a number of plaintiffs filing lawsuits against Merck & Co., Inc. (NYSE:MRK) claiming that its shingles vaccine, Zostavax......(read more)
Flexi-Pricing Scheme Unveiled For Novartis AG (ADR) (NVS) Kisqali In The Face Of Stiff Competition
After recently getting the approval of the U.S. Food and Drug Administration, Novartis AG (ADR) (NYSE:NVS) has announced that a flexible pricing system......(read more)
AstraZeneca PLC (ADR) (AZN)’s Lynparza Trial Results Positive In Competitive Threat To Clovis Oncology Inc (CLVS) And TESARO Inc (TSRO)
Lynparza, an ovarian cancer treatment developed by AstraZeneca PLC (ADR) (NYSE:AZN) has demonstrated its ability to slow down disease progression. AstraZeneca......(read more)
Expert Stock Picks: Should You Buy Skyworks Solutions Inc (SWKS)?
The head of technical analysis at Oppenheimer (1), Ari Wald, is bullish on Skyworks Solutions Inc (NASDAQ:SWKS). He cites that technology is currently......(read more)
Catalyst Pharmaceuticals Inc (CPRX): Here’s What’s Next
After struggling throughout the latter half of 2016 with various development and regulatory pressures, Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) has......(read more)
Cellular Biomedicine Group Inc (CBMG) Expands GMP Capacity For The Growing Chinese Market
By Pablo Erbar Cellular Biomedicine Group Inc (NASDAQ:CBMG) is a developer of proprietary cell therapies for the treatment of cancer and other degenerative......(read more)
Investors Increasingly Bullish After Vuzix Corporation (VUZI) Announces Development Agreement With Toshiba Corp NPV (TOSBF)
By Pablo Erbar Last month Vuzix Corporation (NASDAQ:VUZI) disclosed plans to build a pair of custom smart glasses for Toshiba Client Solutions Co. Ltd......(read more)
Why Intel Corporation (INTC) Is Betting On Driverless Technology
The world’s largest and most-valued semiconductor chip maker, Intel Corporation (NASDAQ:INTC), is about to buy Israeli driverless car technology company......(read more)
Aurinia Pharmaceuticals Inc (AUPH) In A Common Shares Public Offering To Raise Over $150 Million
In the Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) public offering, common shares totaling 22,300,000 will be offered at $6.75 a share. The biopharmaceutical......(read more)
Here’s What Just Happened With AstraZeneca PLC (ADR) (AZN), TESARO Inc (TSRO) And Clovis Oncology Inc (CLVS)
It’s been a big week for PARP inhibitors. AstraZeneca PLC (ADR) (NYSE:AZN) just put out data from a phase 3 investigation of its lead PARP asset Lynparza......(read more)
Canadian Banks For Long Term Dividend Growth Investors
I have owned shares of the largest Canadian Banks as a long-term investment for over four years now. I initiated a position in those five banks in early......(read more)
CVS Health Corp (CVS) Pledges Funds For Youth Anti-Smoking Campaign
In its efforts to contribute to a generation that is tobacco-free, CVS Health Corp (NYSE:CVS) has devoted $50 million for a five-year program. The drug......(read more)
AstraZeneca PLC (ADR) (AZN) Rejected Drugs To Be Reconsidered
AstraZeneca plc (ADR) (NYSE:AZN) is reconsidering some of its rejected drugs, as they could possess potential in curing a disease they were not initially......(read more)
Two Biotech Catalysts To Watch Right Now: Bioline RX Ltd (BLRX) And AMAG Pharmaceuticals, Inc. (AMAG)
It’s been a busy quarter in the biotechnology space, but it’s not over yet. This month promises to bring with it a flurry of end of quarter catalysts......(read more)
3 Hedge Funds Still Love Valeant Pharmaceuticals Intl Inc (VRX)
Pershing Square Capital Management, managed by Bill Ackman, sold its entire stake in Valeant Pharmaceuticals Intl Inc (NYSE:VRX) on Monday. The investor......(read more)
Marijuana Stocks: Sean Williams, GW Pharmaceuticals PLC- ADR (GWPH), And Cara Therapeutics Inc (CARA)
One of the most compelling markets for investors is the burgeoning legal cannabis industry. With medical marijuana legal in 28 states and recreational......(read more)
Food And Drug Administration Accepts Allergan PLC (AGN) Vraylar For Review As A Supplemental Drug
Allergan plc Ordinary Shares (NYSE:AGN) has announced that an application to have new clinical data for Vraylar evaluated has been accepted by the Food......(read more)
Coverage For Medtronic PLC (MDT) Micra Approved By Centers For Medicare & Medicaid
The Centers for Medicare & Medicaid Services (CMS) has granted approval to the Micra Transcatheter pacemaker (Micra TPS) that is manufactured by Medtronic......(read more)
Is The Radius Health Inc (RDUS) Dip A Discount Opportunity?
Every so often, a biotech company takes a hit on some news that seems negative, and at first glance is, but is likely only temporary in terms of impact......(read more)
Preferred Stock ETFs Face New Test
Preferred stocks offer the distinction of being unique hybrid instruments with qualities of both stocks and bonds. In that manner, they offer healthy......(read more)
